Average Co-Inventor Count = 4.36
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (60 from 290 patents)
2. Other (4 from 832,680 patents)
3. The State University of New York (3 from 1,991 patents)
4. Dupont Pharmaceuticals Company (3 from 106 patents)
5. The Procter Gamble Company (2 from 17,164 patents)
6. Dupont Pharmaceuticals, Inc. (1 from 15 patents)
7. Emata Pharmaceuticals, Inc (1 from 1 patent)
74 patents:
1. 10272392 - Porous graphene based composite membranes for nanofiltration, desalination, and pervaporation
2. 10112150 - Porous graphene based composite membranes for nanofiltration, desalination, and pervaporation
3. 9931611 - Modified hydrophobic sponges
4. 9724669 - Modified hydrophobic sponges
5. 9526769 - Macrocylic oximyl hepatitis C protease inhibitors
6. 9242974 - Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
7. 8962551 - Quinoxalinyl derivatives
8. 8951998 - Quinoxaline-containing compounds as hepatitis C virus inhibitors
9. 8940688 - Fluorinated tripeptide HCV serine protease inhibitors
10. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
11. 8785377 - Tetrazolyl macrocyclic hepatitis C serine protease inhibitors
12. 8552162 - Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
13. 8501682 - Difluorinated tripeptides as HCV serine protease inhibitors
14. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors
15. 8426360 - Carbocyclic oxime hepatitis C virus serine protease inhibitors